Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PULSE BIOSCIENCES, INC.PLSE · Entity 1151 | Chief Strategy Officer | September 24, 2024 | September 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PULSE BIOSCIENCES, INC.
Report date September 24, 2024 · Filed September 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,880 |
Reported balance
After 2024-09-24 transaction · row 1
1 source rowRow 1 · 2024-09-24 · Other · Acquired 3,000 · Balance 93,880 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 21,240 |
Reported balance
After 2024-09-24 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-09-24 · Other · Acquired 1,240 · Balance 21,240 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 1 | 8,321 |
Reported balance
After 2024-09-24 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2024-09-24 · Other · Acquired 322 · Balance 8,321 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 2 | 8,421 |
Reported balance
After 2024-09-24 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2024-09-24 · Other · Acquired 322 · Balance 8,421 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 3 | 8,521 |
Reported balance
After 2024-09-24 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2024-09-24 · Other · Acquired 322 · Balance 8,521 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | Direct | 0 |
Reported balance
After 2024-09-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-09-24 · Other · Disposed 1,500 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | Direct | 0 |
Reported balance
After 2024-09-24 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-09-24 · Other · Disposed 1,500 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectSpouse | 1 |
Reported balance
After 2024-09-24 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-09-24 · Other · Disposed 620 · Balance 1 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectSpouse | 1 |
Reported balance
After 2024-09-24 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-09-24 · Other · Disposed 620 · Balance 1 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 1 | 0 |
Reported balance
After 2024-09-24 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 1 | 0 |
Reported balance
After 2024-09-24 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 2 | 0 |
Reported balance
After 2024-09-24 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 2 | 0 |
Reported balance
After 2024-09-24 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 3 | 0 |
Reported balance
After 2024-09-24 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 3 | 0 |
Reported balance
After 2024-09-24 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 127 | $7.01 | $890.27 |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 572 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 714 | $7.01 | $5,005.14 |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 3,214 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:05 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 5,713 | $7.01 | $40,048.13 |
DisclosureSEC source: 0001209191-20-037225 · doc4.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,713 F1 · kind: The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| May 18, 2020 Filed May 19, 2020 18:24 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 15,901 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-20-030676 · doc4.xml · derivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,901 Underlying: Common Stock · 15,901 shares Expires 2030-05-18 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 18, 2020 Filed May 19, 2020 18:24 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-20-030676 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-18 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 16, 2019 Filed May 17, 2019 16:16 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0001209191-19-030895 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 18, 2019 Filed Mar 19, 2019 17:18 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $18.25 | $0.00 |
DisclosureSEC source: 0001209191-19-020376 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-03-18 F1 · derivative.exercise_date: One-third (1/3) of the shares subject to the option will vest on the one-year anniversary of the grant date, and the remaining shares will vest monthly over the following two years, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 21:06 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 445 | $12.15 | $5,408.09 |
DisclosureSEC source: 0001209191-17-053233 · doc4.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 445 Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 21:06 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 445 | $12.21 | $5,435.23 |
DisclosureSEC source: 0001209191-17-053233 · doc4.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 445 Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 21:06 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 445 | $12.21 | $5,433.01 |
DisclosureSEC source: 0001209191-17-053233 · doc4.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 445 Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 21:06 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 2,500 | $12.36 | $30,893.75 |
DisclosureSEC source: 0001209191-17-053233 · doc4.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 2,500 Read SEC document |
| May 16, 2017 Filed May 18, 2017 16:07 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $27.14 | $0.00 |
DisclosureSEC source: 0001209191-17-033570 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-05-16 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period that will begin on June 1, 2017, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.